Literature DB >> 28646483

From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy.

R Mager1, M P Brandt2, H Borgmann2, K M Gust3, A Haferkamp2, M Kurosch2.   

Abstract

PURPOSE: To investigate the learning curve of a novice in MRI/TRUS software fusion biopsy and to compare his results with the expert standard at our institution.
METHODS: Overall 126 MRI/TRUS fusion-guided transrectal biopsies were performed using an electromagnetic tracking ultrasonography platform. The learning progress of the novice was evaluated comparing his initial 42 procedures (group A) with his following 42 (group B). The institution's expert standard (group C), which was compared to the novice's groups, was defined by the expert's experience of 42 MRI/TRUS fusion biopsies. Primary learning curve parameters were targeted biopsy detection quotient and biopsy time.
RESULTS: Overall detection of prostate cancer was 64% (27/42), 62% (26/42) and 62% (26/42) in groups A, B and C, respectively. The median target biopsy detection quotient significantly increased (p = 0.04) in group B (0.75, interquartile range (IQR) 0.25-1.0) compared to group A. (0.33, IQR 0.2-0.5). Group C revealed a median detection quotient of 0.5 (IQR 0.25-0.76) that did not differ significantly from the novice's groups (p = 0.2). Median biopsy time was significantly higher in group A (45 min, IQR 33-50 min) compared to groups B (25 min, IQR 23-29 min) and C (24 min, IQR 16-46 min) (p < 0.01).
CONCLUSIONS: The present study revealed the individual learning curve of a novice in MRI/TRUS fusion biopsy and demonstrated significant learning progress regarding targeted biopsy detection quotient and biopsy time.

Entities:  

Keywords:  Biopsy time; Learning progress; Prostate cancer; Targeted biopsy quotient; Training

Mesh:

Year:  2017        PMID: 28646483     DOI: 10.1007/s11255-017-1642-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Poor standard mp-MRI and routine biopsy fail to precisely predict intraprostatic tumor localization.

Authors:  Andrea Billing; Alexander Buchner; Christian Stief; Alexander Roosen
Journal:  World J Urol       Date:  2016-02-24       Impact factor: 4.226

2.  Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer.

Authors:  Winston E Barzell; Myron R Melamed; Paul Cathcart; Caroline M Moore; Hashim U Ahmed; Mark Emberton
Journal:  J Urol       Date:  2012-07-19       Impact factor: 7.450

3.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

4.  Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?

Authors:  Annerleim Walton Diaz; Anthony N Hoang; Baris Turkbey; Cheng William Hong; Hong Truong; Todd Sterling; Soroush Rais-Bahrami; M Minhaj Siddiqui; Lambros Stamatakis; Srinivas Vourganti; Jeffrey Nix; Jennifer Logan; Colette Harris; Michael Weintraub; Celene Chua; Maria J Merino; Peter Choyke; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2013-06-18       Impact factor: 7.450

5.  Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.

Authors:  Hebert Alberto Vargas; Oguz Akin; Asim Afaq; Debra Goldman; Junting Zheng; Chaya S Moskowitz; Amita Shukla-Dave; James Eastham; Peter Scardino; Hedvig Hricak
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

6.  Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?

Authors:  Kalyan C Latchamsetty; Lester S Borden; Christopher R Porter; Marc Lacrampe; Matthew Vaughan; Eugene Lin; Neal Conti; Jonathan L Wright; John M Corman
Journal:  Can J Urol       Date:  2007-02       Impact factor: 1.344

7.  The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer.

Authors:  François Marliere; Philippe Puech; Ahmed Benkirane; Arnauld Villers; Laurent Lemaitre; Xavier Leroy; Nacim Betrouni; Adil Ouzzane
Journal:  World J Urol       Date:  2014-05-12       Impact factor: 4.226

8.  Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.

Authors:  Joseph L Chin; Michele Billia; James Relle; Matthias C Roethke; Ionel V Popeneciu; Timur H Kuru; Gencay Hatiboglu; Maya B Mueller-Wolf; Johann Motsch; Cesare Romagnoli; Zahra Kassam; Christopher C Harle; Jason Hafron; Kiran R Nandalur; Blaine A Chronik; Mathieu Burtnyk; Heinz-Peter Schlemmer; Sascha Pahernik
Journal:  Eur Urol       Date:  2016-01-06       Impact factor: 20.096

9.  Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.

Authors:  Timur H Kuru; Matthias C Roethke; Philip Rieker; Wilfried Roth; Michael Fenchel; Markus Hohenfellner; Heinz-Peter Schlemmer; Boris A Hadaschik
Journal:  BJU Int       Date:  2013-08-13       Impact factor: 5.588

10.  MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.

Authors:  Willemien van den Bos; D M de Bruin; A van Randen; M R W Engelbrecht; A W Postema; B G Muller; I M Varkarakis; A Skolarikos; C D Savci-Heijink; R R Jurhill; P J Zondervan; M P Laguna Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  Eur Radiol       Date:  2015-10-08       Impact factor: 5.315

View more
  7 in total

1.  Association of training level and outcome of software-based image fusion-guided targeted prostate biopsies.

Authors:  Niklas Westhoff; Henning Haumann; Maximilian Christian Kriegmair; Jost von Hardenberg; Johannes Budjan; Stefan Porubsky; Maurice Stephan Michel; Patrick Honeck; Manuel Ritter
Journal:  World J Urol       Date:  2018-12-17       Impact factor: 4.226

2.  Analyzing the learning curves of a novice and an experienced urologist for transrectal magnetic resonance imaging-ultrasound fusion prostate biopsy.

Authors:  Emanuel Darius Cata; Charles Van Praet; Iulia Andras; Pierre Kadula; Razvan Ognean; Maximilian Buzoianu; Daniel Leucuta; Cosmin Caraiani; Attila Tamas-Szora; Karel Decaestecker; Ioan Coman; Nicolae Crisan
Journal:  Transl Androl Urol       Date:  2021-05

3.  Impact of Surgeon's Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores.

Authors:  Magdalena Görtz; Joanne Nyaboe Nyarangi-Dix; Lars Pursche; Viktoria Schütz; Philipp Reimold; Constantin Schwab; Albrecht Stenzinger; Holger Sültmann; Stefan Duensing; Heinz-Peter Schlemmer; David Bonekamp; Markus Hohenfellner; Jan Philipp Radtke
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

4.  A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies.

Authors:  Manuel Ritter; Niklas Westhoff; Fabian Derigs; Samuel Doryumu; Fabian Tollens; Dominik Nörenberg; Manuel Neuberger; Jost von Hardenberg; Maurice Stephan Michel
Journal:  World J Urol       Date:  2021-11-26       Impact factor: 4.226

5.  Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.

Authors:  Armando Stabile; Francesco Giganti; Veeru Kasivisvanathan; Gianluca Giannarini; Caroline M Moore; Anwar R Padhani; Valeria Panebianco; Andrew B Rosenkrantz; Georg Salomon; Baris Turkbey; Geert Villeirs; Jelle O Barentsz
Journal:  Eur Urol Oncol       Date:  2020-03-17

6.  Developing a coordinate-based strategy to support cognitive targeted prostate biopsies and correlative spatial-histopathological outcome analysis.

Authors:  Keiran D Clement; Lizzy Day; Helen Rooney; Matt Neilson; Fiona Birrell; Mark Salji; Elizabeth Norman; Ross Clark; Amit Patel; John Morrison; Hing Y Leung
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

7.  The urologist's learning curve of "in-bore" magnetic resonance-guided prostate biopsy.

Authors:  Zohar A Dotan; Orith Portnoy; Barak Rosenzweig; Tomer Drori; Orit Raz; Gil Goldinger; Gadi Shlomai; Dorit E Zilberman; Moshe Shechtman; Jacob Ramon
Journal:  BMC Urol       Date:  2021-12-06       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.